We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Add Teledyne Technologies (TDY) Stock
Read MoreHide Full Article
Earnings estimates for Teledyne Technologies Incorporated (TDY - Free Report) for 2019 and 2020 have moved up 6.64% and 11.19% on a year-over-year basis to $9.47 and $10.53, respectively. Revenue estimates for 2019 and 2020 rose 6.69% and 4.17% on a year-over-year basis to $3.10 billion and $3.23 billion, respectively.
Let’s focus on the factors that make the stock an appropriate pick at the moment.
The company has an average four-quarter positive earnings surprise of 6.79%.
Price Performance & Long-Term Growth
In the past 12 months, Teledyne Technologies’ shares have rallied 26.5% compared with the industry’s rise of 13.8%.
The company’s long-term (3 to 5 years) earnings growth is pegged at 7.50%.
Debt/Capital &Current Ratio
Teledyne Technologies is consistently striving to preserve balance-sheet strength. Currently, the company has a current ratio of 1.54. Its financial strength will enable the company to meet near-term debt obligation. Its long-term debt-to-capital ratio is 23.57%, lower than the Zacks S&P 500 composite’s level of 43.02% and the industry’s 28.59%.
Solid Backlog
Higher contract wins from the Pentagon and other U.S. allies for cost-effective defense solutions are growth drivers and boost Teledyne Technologies' backlog. Sales in each segment and major product categories increased during the first quarter of 2019. Backlog continued to grow as orders exceeded sales for the fifth consecutive quarter. An impressive backlog trend indicates revenue growth in the upcoming quarters.
Other Key Picks
Some other top-ranked stocks from the same industry are Aerojet Rocketdyne Holdings, Inc , Astronics Corporation (ATRO - Free Report) and Heico Corporation (HEI - Free Report) . All the three stocks sport a Zacks Rank of 1(Strong Buy).
Aerojet Rocketdyne pulled off an average positive earnings surprise of 36.67% in the last four quarters. The company’s long-term earnings growth is pegged at 5.50%
Astronics came up with an average positive earnings surprise of 22.55% in the last four quarters. The company’s long-term earnings growth is pegged at 10%
Heico pulled off an average positive earnings surprise of 9.47% in the last four quarters. The company’s long-term earnings growth is pegged at 12.10%
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Here's Why You Should Add Teledyne Technologies (TDY) Stock
Earnings estimates for Teledyne Technologies Incorporated (TDY - Free Report) for 2019 and 2020 have moved up 6.64% and 11.19% on a year-over-year basis to $9.47 and $10.53, respectively. Revenue estimates for 2019 and 2020 rose 6.69% and 4.17% on a year-over-year basis to $3.10 billion and $3.23 billion, respectively.
Let’s focus on the factors that make the stock an appropriate pick at the moment.
Zacks Rank &Surprise History
The stock currently sports a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The company has an average four-quarter positive earnings surprise of 6.79%.
Price Performance & Long-Term Growth
In the past 12 months, Teledyne Technologies’ shares have rallied 26.5% compared with the industry’s rise of 13.8%.
The company’s long-term (3 to 5 years) earnings growth is pegged at 7.50%.
Debt/Capital &Current Ratio
Teledyne Technologies is consistently striving to preserve balance-sheet strength. Currently, the company has a current ratio of 1.54. Its financial strength will enable the company to meet near-term debt obligation. Its long-term debt-to-capital ratio is 23.57%, lower than the Zacks S&P 500 composite’s level of 43.02% and the industry’s 28.59%.
Solid Backlog
Higher contract wins from the Pentagon and other U.S. allies for cost-effective defense solutions are growth drivers and boost Teledyne Technologies' backlog. Sales in each segment and major product categories increased during the first quarter of 2019. Backlog continued to grow as orders exceeded sales for the fifth consecutive quarter. An impressive backlog trend indicates revenue growth in the upcoming quarters.
Other Key Picks
Some other top-ranked stocks from the same industry are Aerojet Rocketdyne Holdings, Inc , Astronics Corporation (ATRO - Free Report) and Heico Corporation (HEI - Free Report) . All the three stocks sport a Zacks Rank of 1(Strong Buy).
Aerojet Rocketdyne pulled off an average positive earnings surprise of 36.67% in the last four quarters. The company’s long-term earnings growth is pegged at 5.50%
Astronics came up with an average positive earnings surprise of 22.55% in the last four quarters. The company’s long-term earnings growth is pegged at 10%
Heico pulled off an average positive earnings surprise of 9.47% in the last four quarters. The company’s long-term earnings growth is pegged at 12.10%
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>